Literature DB >> 10575326

Sibling orders of schizophrenic patients in Austria and Pakistan.

T Stompe1, G Ortwein-Swoboda, A Friedmann, H R Chaudhry.   

Abstract

The influence of siblings on the socialization of the individual has been recognized as a fact by both psychology and sociology. The significance of sibling order for the outbreak of psychiatric diseases on the other hand is still discussed controversially. In our study, we compared the expected values and the positions actually found in the sibling order of 379 (233 males, 146 females) Austrian and 144 (101 males, 43 females) Pakistani patients diagnosed with schizophrenia according to DSM-IV (295). The position in the sibling order had no influence on the outbreak of schizophrenia in Austria; with Austrian schizophrenics, the results found were very near to the expected values. In Pakistan on the other hand, the eldest brothers from families with 2-4 siblings had a significantly higher risk of falling ill. The investigation of the composition of the sibships of schizophrenic patients also showed a high overrepresentation of men in the firstborn position in Pakistan. These facts seem to exercise influences that may either protect against the outbreak or encourage it. The differences found agree well with the fact that in Pakistan, both the gender of a child and the position in the sibling order entail different ways of treatment and different scopes of responsibility. Socialization in Austria on the other hand, at least in the recent decades, has become very uniform for both sexes, regardless of the sibling position. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Year:  1999        PMID: 10575326     DOI: 10.1159/000029101

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  1 in total

1.  Schizophrenia risk factors in exceptional achievers: a re-analysis of a 60-year-old database.

Authors:  Andrei Szöke; Baptiste Pignon; Franck Schürhoff
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.